|
Market Closed -
Nasdaq
04:00:00 2026-10-02 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.8567 USD | -4.93% |
|
-24.19% | -84.05% |
| Sep. 23 | Compass Therapeutics Shares Drop After Downgrade From Wedbush | MT |
| Sep. 23 | Wedbush Downgrades Compass Therapeutics to Neutral From Outperform, Cuts Price Target to $1 From $5 | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CMPX | Delayed | |
CBOE
| CMPX | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.46 | 2.53 | 2.4 |
| Spread/Res. | -41.32% | -66.14% | -64.30% |
| Spread/Supp. | +7.09% | +201.97% | +144.21% |
| Support | 0.8 | 0.2837 | 0.3508 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CMPX Stock
- Charts Compass Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
